Indirect-acting ACh receptor agonists (reversible cholinesterase inhib) Flashcards
Indirect-acting ACh receptor agonists (2 main groups)
Cholinesterase inhibitors.
Type V phosphodiesterase inhibitors.
Cholinesterase inhibitors (2 groups)
Reversible cholinesterase inhibitors.
Quasi-reversible cholinesterase inhibitors (organophosphate compounds)
Reversible cholinesterase inhibitors (7 drugs)
Edrophonium Neostigmine Pyridostigmine Physostigmine Donepezil Galantamine Rivastigmine
Treatment of myasthenia gravis
Cholinesterase inhibitors + corticosteroids / immunosuppressant.
Thymectomy.
Cholinesterase for long-term treatment: neostigmine and pyridostigmine
Too high or too low doses of cholinesterase inhibitors in myasthenia gravis may cause (two crises) and why.
Too low doses: myasthenic crisis (no ACh causes muscle weakness).
Too high doses: cholinergic crisis (too much ACh causes a depolarization blockade and muscle weakness).
Edrophonium - MOA
Prevents hydrolysis of ACh by cholinesterase and increases concentrations of ACh
Edrophonium - indications
Diagnosis of myasthenia gravis.
Distinguishing myasthenic crisis (decreases muscle weakness) from cholinergic crisis (increases muscle weakness).
Reversible cholinesterase inhibitors that cross the BBB
Physostigmine
Donepezil
Galantamine
Rivastigmine
Neostigmine, physostigmine, pyridostigmine - MOA
Act as slowly hydrolyzing substrates for cholinesterase, and increases the concentration of ACh
Drugs used to counteract curariform drug action postoperatively
Neostigmine, pyridostigmine, edrophonium
Neostigmine - indications
Postoperative urinary retention and abdominal distention
Physostigmine - indications
Given parenterally as antidote to atropine (or other antimuscarinic) overdose
Reversible cholinesterase inhibitors used to treat Alzheimers
Donepezil
Galantamine
Rivastigmine